Skip to main content

Want a detailed portfolio tracker?

Aditxt (ADTX) P/E (2020 - 2026)

Aditxt (ADTX) P/E from Jun 30, 2020 to Jun 5, 2026. The TTM Aditxt (ADTX) P/E is -0.05. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Aditxt (ADTX)

YearP/EChange
2026-0.05-99.97%
2025-146.20-99.98%
2024-939.36K-99.93%
2023-1.31B-85.64%
2022-9.14B-95.69%
2021-212.26B-74.23%
2020-823.55BN/A

Comparison Aditxt (ADTX) P/E with competitors

Aditxt (ADTX) P/E is -0.05.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-103.38%
NBYStablecoin Development Corp0.00-108.54%
ENLVEnlivex Ltd0.07-248.51%
FGENFibroGen Inc0.24-576.56%
CHRSCoherus Biosciences Inc0.85-1784.60%
FBIOFortress Biotech Inc0.95-1984.13%
ORMPOramed Pharmaceuticals Inc1.50-3084.03%
AGENAgenus Inc3.01-6075.01%
INVAInnoviva Inc3.15-6361.70%
VXRTVaxart Inc3.55-7147.31%
CRMDCorMedix Inc3.63-7303.56%
CVACCureVac N.V.4.45-8926.02%
GLPGGalapagos NV4.86-9746.38%
SRPTSarepta Therapeutics Inc4.88-9792.44%
ABEOAbeona Therapeutics Inc5.39-10795.85%
ABUSArbutus Biopharma Corp5.60-11209.01%
ZVRAZevra Therapeutics Inc5.89-11787.94%
SPROSpero Therapeutics Inc6.23-12465.36%
CGENCompugen Ltd6.31-12635.11%
RIGLRigel Pharmaceuticals6.87-13743.15%
SLXNSilexion Therapeutics Corp7.30-14584.95%
OMEROmeros Corporation9.26-18481.46%
AUPHAurinia Pharmaceuticals Inc9.58-19129.09%
PLXProtalix BioTherapeutics Inc10.89-21722.00%
ACADAcadia Pharmaceuticals Inc11.73-23384.76%
TBPHTheravance Biopharma Inc12.26-24444.16%
HRMYHarmony Biosciences Holdings Inc13.82-27537.38%
SABSSAB Biotherapeutics Inc14.14-28164.76%
NAGENiagen Bioscience Inc14.82-29518.60%
INCYIncyte Corp15.82-31512.71%
REGNRegeneron Pharmaceuticals Inc15.86-31580.41%
PBYIPuma Biotechnology Inc17.32-34477.09%
CPRXCatalyst Pharmaceuticals Inc17.44-34722.48%
EXELExelixis Inc17.54-34918.44%
TGTXTG Therapeutics Inc18.97-37753.56%
MDXGMimedx Group Inc20.55-40903.17%
XOMAXOMA Royalty Corp22.87-45514.62%
ARGXArgen X SE24.30-48340.41%
CTMXCytomX Therapeutics Inc24.82-49378.97%
XOMAOXOMA Royalty Corp25.34-50418.71%
HALOHalozyme Therapeutics Inc25.62-50972.43%
XOMAPXOMA Royalty Corp25.67-51064.56%
VRTXVertex Pharmaceuticals Inc27.99-55679.77%
RPRXRoyalty Pharma plc - Class A28.69-57055.25%
SLNOSoleno Therapeutics Inc29.02-57706.06%
ASNDAscendis Pharma A/S30.09-59830.81%
LGNDLigand Pharmaceuticals Inc - Class B37.91-75369.20%
APLSApellis Pharmaceuticals Inc39.02-77571.39%
BMRNBiomarin Pharmaceutical Inc42.21-83905.95%
KRYSKrystal Biotech Inc45.34-90123.37%
ONCBeiGene Ltd69.54-138163.26%
PHARPharming Group N.V.75.03-149053.28%
TECHBio-Techne Corp101.96-202524.78%
VCELVericel Corp109.92-218334.17%
ALNYAlnylam Pharmaceuticals Inc117.96-234303.99%
GMABGenmab140.29-278628.64%
TLXTelix Pharmaceuticals Ltd162.15-322032.86%
CORTCorcept Therapeutics Inc212.86-422700.26%